Can nitrofurantoin be given through a nasogastric tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Nitrofurantoin Be Given Through an NG Tube?

Yes, nitrofurantoin can be administered through a nasogastric tube, but only for lower urinary tract infections (cystitis), NOT for febrile UTIs or pyelonephritis where systemic absorption is required.

Critical Distinction Based on Infection Type

For Lower UTI (Cystitis) - NG Administration is Acceptable

  • Nitrofurantoin works primarily through urinary concentration, not systemic absorption 1
  • The FDA label states that "blood concentrations at therapeutic dosage are usually low" and the drug "is highly soluble in urine" 1
  • Food increases bioavailability by allowing better dissolution in gastric juices 1, which can be replicated with NG administration if given with enteral feeds
  • Current guidelines recommend nitrofurantoin 100 mg twice daily for 5 days as first-line therapy for uncomplicated UTI 2

For Febrile UTI/Pyelonephritis - NG Administration is CONTRAINDICATED

Pediatric guidelines explicitly state: "Agents that are excreted in the urine but do not achieve therapeutic concentrations in the bloodstream, such as nitrofurantoin, should not be used to treat febrile infants with UTIs, because parenchymal and serum antimicrobial concentrations may be insufficient to treat pyelonephritis or urosepsis" 3.

This principle applies to adults as well - systemic infections require adequate tissue penetration.

Practical Administration Considerations

Preparation Requirements

  • Nitrofurantoin macrocrystals capsules can be opened and the contents mixed with water for NG administration 4
  • The suspension should be administered immediately after preparation
  • Flush the tube with 30 mL water before and after administration to prevent tube obstruction 4, 5

Timing with Enteral Feeds

  • Administer WITH enteral nutrition or food 1
  • The FDA label specifically notes that "the presence of food or agents delaying gastric emptying can increase the bioavailability of nitrofurantoin macrocrystals" 1
  • This improves both absorption and tolerability

Important Contraindication

  • Do NOT give with magnesium trisilicate-containing antacids - these reduce both rate and extent of absorption through adsorption 1
  • Separate administration by at least 2 hours if antacids are necessary

Common Pitfalls to Avoid

  1. Using nitrofurantoin for systemic infections - The low serum concentrations make it inappropriate for pyelonephritis, even via NG tube 3

  2. Administering on empty stomach - This reduces bioavailability and increases GI intolerance 1

  3. Inadequate tube flushing - Can lead to tube obstruction with the macrocrystal formulation 4

  4. Assuming bioequivalence - While NG administration is feasible for lower UTI, research shows that some medications have reduced bioavailability via NG tube 6, though this is less critical for nitrofurantoin given its urinary mechanism of action

Clinical Algorithm

Step 1: Determine infection type

  • Lower UTI (dysuria, frequency, urgency without fever) → NG administration acceptable
  • Febrile UTI/pyelonephritis (fever, flank pain, systemic symptoms) → Choose alternative antibiotic with systemic absorption

Step 2: If lower UTI, prepare for NG administration

  • Open capsule, mix contents with 10-20 mL water
  • Administer during or immediately after enteral feeding
  • Flush tube with 30 mL water

Step 3: Monitor for efficacy

  • Symptom improvement expected within 24-48 hours
  • Complete full 5-day course 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.